SEC Form 4 · accession 0001070081-19-000020
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christine Marie Utter
Officer — Principal Financial Officer
Period of report
Mar 5, 2019
Accepted (ET)
Mar 7, 2019 · 9:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 5, 2019 | S | 1,509 | $34.78 | D | 5,937 | D | |
| Common StockF3 | Mar 5, 2019 | S | 1,000 | $35.25 | D | 4,937 | D | |
| Common Stock | Mar 5, 2019 | M | 1,150 | $10.85 | A | 6,087 | D | |
| Common StockF4 | Mar 5, 2019 | S | 540 | $34.71 | D | 5,547 | D | |
| Common StockF5 | Mar 5, 2019 | S | 610 | $35.17 | D | 4,937 | D | |
| Common Stock | Mar 5, 2019 | M | 18,750 | $13.10 | A | 23,687 | D | |
| Common StockF6 | Mar 5, 2019 | S | 9,929 | $34.75 | D | 13,758 | D | |
| Common StockF7 | Mar 5, 2019 | S | 8,821 | $35.21 | D | 4,937 | D | |
| Common Stock | Mar 5, 2019 | M | 6,300 | $11.23 | A | 11,237 | D | |
| Common StockF4 | Mar 5, 2019 | S | 2,760 | $34.70 | D | 8,477 | D | |
| Common StockF8 | Mar 5, 2019 | S | 3,540 | $35.17 | D | 4,937 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Buy)F9 | $10.85 | Mar 5, 2019 | M | 1,150 | D | — | May 15, 2023 | Common Stock | 1,150 | 0 | D |
| Stock Option (Right To Buy)F10 | $13.10 | Mar 5, 2019 | M | 18,750 | D | — | Jun 2, 2027 | Common Stock | 18,750 | 6,250 | D |
| Stock Option (Right To Buy)F11 | $11.23 | Mar 5, 2019 | M | 6,300 | D | — | Jan 2, 2027 | Common Stock | 6,300 | 6,300 | D |
| Stock Option (Right To Buy)F9 | $490.80 | holding | — | — | — | — | Apr 27, 2021 | Common Stock | 74 | 74 | D |
| Stock Option (Right To Buy)F9 | $218.40 | holding | — | — | — | — | Jan 10, 2022 | Common Stock | 21 | 21 | D |
| Stock Option (Right To Buy)F9 | $27.05 | holding | — | — | — | — | Jan 28, 2024 | Common Stock | 3,369 | 3,369 | D |
| Stock Option (Right To Buy)F9 | $40.45 | holding | — | — | — | — | Sep 23, 2024 | Common Stock | 4,688 | 4,688 | D |
| Stock Option (Right To Buy)F9 | $51.00 | holding | — | — | — | — | Jan 2, 2025 | Common Stock | 17,800 | 17,800 | D |
| Stock Option (Right To Buy)F12 | $30.86 | holding | — | — | — | — | Jan 3, 2026 | Common Stock | 11,000 | 11,000 | D |
| Stock Option (Right To Buy)F13 | $18.01 | holding | — | — | — | — | Jan 2, 2028 | Common Stock | 40,000 | 40,000 | D |
| Stock Option (Right To Buy)F14 | $33.02 | holding | — | — | — | — | Jan 21, 2029 | Common Stock | 42,500 | 42,500 | D |
| Stock Option (Right To Buy)F15 | $33.02 | holding | — | — | — | — | Jan 21, 2029 | Common Stock | 10,100 | 10,100 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan.
- F10This option was granted on June 2, 2017, and vests over two years, with 50% of the shares underlying the option vesting on June 2, 2018, and an additional 12.5% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on September 2, 2018.
- F11This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.
- F12This option was granted on January 4, 2016 and vests over four years, with 25% of the shares underlying the option vested on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
- F13This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.
- F14This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.
- F15This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023.
- F2This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $34.29 to $34.98 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $35.00 to $35.60 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $34.29 to $34.94 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F5This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $34.96 to $35.40 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F6This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $34.06 to $34.99 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F7This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $35.00 to $35.71 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F8This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $34.96 to $35.44 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F9Currently exercisable.